Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Mater Chem B ; 11(42): 10189-10205, 2023 11 01.
Article in English | MEDLINE | ID: mdl-37853786

ABSTRACT

The field of stimuli-responsive supramolecular biomaterials has rapidly advanced in recent years, with potential applications in diverse areas such as cancer theranostics, tissue engineering, and catalysis. However, designing molecular materials that exhibit predetermined hierarchical self-assembly to control the size, morphology, surface chemistry, and responsiveness of the final nanostructures remains a significant challenge. In this study, we present a divergent synthetic approach for the fabrication of spherical micelles and functional 1D-glyconanotube-based photoresponsive gels from structurally related diazobenzene/diacetylene glycolipids. The resulting nanostructures were characterized using NMR, TEM, and SEM, confirming the formation of spherical and tubular nanostructures in both the gel and solution states. Upon UV irradiation, a reversible gel-sol transition was observed, resulting from the photoswitching of the azobenzene unit from the stretched trans form to the compact, metastable cis form. Our gels were shown to enable spatio-temporal control of the adhesion and release of the lectin Concanavalin A, demonstrating potential use as regenerable biomaterials to fight against infections with toxins and pathogens. Additionally, our micelles and gels were evaluated as nanocontainers for loading and controlled release of hydrophobic dyes and antitumoural agents, suggesting their possible use as smart theranostic drug delivery systems.


Subject(s)
Lectins , Micelles , Drug Delivery Systems , Biocompatible Materials/chemistry , Gels
2.
ACS Appl Bio Mater ; 4(6): 4789-4799, 2021 06 21.
Article in English | MEDLINE | ID: mdl-35007028

ABSTRACT

Hepatocellular carcinoma (HCC) is the sixth most common neoplasia and the fourth most common cause of cancer-related mortality worldwide. Sorafenib is the first-line molecular therapy for patients in an advanced stage of HCC. However, the recommended clinical dose of Sorafenib is associated with several complications, which derive from its lack of cell specificity and its very low water solubility. To circumvent these drawbacks, in the present study we developed two sugar-coated polydiacetylene-based nanomicelles-Sorafenib carriers targeting mannose and asialoglycoprotein receptors (MR and ASGPR, respectively). The strategies allowed the inducement of apoptosis and reduction of cell proliferation at a nanomolar, instead of micromolar, range in liver cancer cells. The study showed that, contrary to literature data, Sorafenib included into the pMicMan (Man = mannose) vector (targeting MR) is more efficient than pMicGal (Gal = galactose) (targeting ASGPR). Indeed, pMicMan increased the endosomal incorporation with an increased intracellular Sorafenib concentration that induced apoptosis and reduced cell proliferation at a low concentration range (10-20 nM).


Subject(s)
Antineoplastic Agents/administration & dosage , Carcinoma, Hepatocellular/drug therapy , Galactose/administration & dosage , Liver Neoplasms/drug therapy , Mannose/administration & dosage , Nanoparticles/administration & dosage , Polyacetylene Polymer/administration & dosage , Sorafenib/administration & dosage , Antineoplastic Agents/chemistry , Apoptosis/drug effects , Asialoglycoprotein Receptor/metabolism , Carcinoma, Hepatocellular/metabolism , Cell Proliferation/drug effects , Endosomes/metabolism , Galactose/chemistry , Hep G2 Cells , Humans , Liver Neoplasms/metabolism , Mannose/chemistry , Mannose Receptor/metabolism , Micelles , Nanoparticles/chemistry , Polyacetylene Polymer/chemistry , Sorafenib/chemistry
3.
Int J Nanomedicine ; 14: 3245-3263, 2019.
Article in English | MEDLINE | ID: mdl-31190792

ABSTRACT

BACKGROUND: Bacterial resistance to antibiotics is one of the biggest challenges facing medicine today. Anti-adhesive therapy, using inhibitors of bacterial adhesion to epithelial cells, one of the first stages of infection, is a promising approximation in this area. The size, shape, number of sugar and their placement are variables that have to be taken into account in order to develop multivalent systems able to inhibit the bacterial adhesion based on sugar-lectin interaction. MATERIALS AND METHODS: In the present work we report a modular approach for the synthesis of water-soluble 1D-carbon nanotube-sugar nanoconstructs, with the necessary flexibility to allow an efficient sugar-lectin interaction. The method is based on the reaction of aryl diazonium salts generated in situ from aniline-substituted mannose and lactose derivatives with single wall carbon nanotubes (SWCNTs) sidewalls. RESULTS: Two hybrid nanosystems, I-II, exposing mannose or lactose and having a tetraethylene glycol spacer between the sugar and the nanotube sidewall were rapidly assembled and adequately characterized. The sweet nano-objects were then tested for their ability to agglutinate and selectively inhibit the growth of uropathogenic Escherichia coli. These studies have shown that nanosystem I, exposing mannose on the nanotube surface is able to agglutinate and to inhibit the bacterial growth unlike nano-objects II exposing lactose. CONCLUSION: The results reported constitute a proof of principle in using mannose-coated 1D-carbon nanotubes as antiadhesive drugs that compete for FimH binding and prevent the uropathogenic bacteria from adhering to the urothelial surface.


Subject(s)
Escherichia coli/cytology , Nanotubes, Carbon/chemistry , Agglutination , Bacterial Adhesion/drug effects , Escherichia coli/drug effects , Escherichia coli/ultrastructure , Mannose/chemistry , Nanotubes, Carbon/ultrastructure , Polysaccharides/chemical synthesis , Polysaccharides/chemistry , Surface Properties
SELECTION OF CITATIONS
SEARCH DETAIL
...